Steven
Jacobson Ph.D., Senior InvestigatorDr. Jacobson received his B.A. from Temple University and his Ph.D. from the Rennselear Polytechnic Institute where he earned
his degree in Virology. The focus of his research was on persistent virus infections. In 1981, Dr. Jacobson joined the Neuroimmunology
Branch as a postdoctoral research fellow in immunology as a National Multiple Sclerosis Society Fellow. In 1993, he received
tenure and formed the Viral Immunology Section to study the role of human viruses in the pathogenesis of chronic progressive
neurologic disease. Dr. Jacobson's laboratory is studying virological, immunological, and molecular mechanisms associated
with the human T lymphotropic virus type-I associated myelopathy/tropical spastic paraparesis and the association of virus
in multiple sclerosis.
Laboratory StaffNahid Akhyani, B.S. Research Assistant
301-402-
6391
Julie Fortheringham, Ph.D. Postdoctoral Fellow
Kazunori Fugo, M.D., Ph.D. Visiting Fellow
Christian Grant, Ph.D. Postdoctoral Fellow
Steven Jacobson, Ph.D. Senior Investigator
301-496-
0519
Norihiro Takenouchi, M.D., Ph.D. Visiting Fellow
Oh Unsong, M.D. Clinical Fellow
Elizabeth Williams, B.S. Research Assistant
Karen Yao, B.S. Predoctoral Fellow
- -
Research InterestsHuman T lymphotropic virus type I (HTLV-I) is associated with a chronic progressive neurological disorder known as HTLV-I-associated
myelopathy/tropical spastic paraparesis (HAM/TSP), a disease clinically similar to the chronic progressive form of multiple
sclerosis (MS). Other viruses such as human herpes virus type 6 (HHV-6) have been associated with MS. An understanding of
the pathogenesis of a neurologic disease with a known viral etiology will aid in defining similar mechanisms of pathogenesis
in MS, a disease of unknown etiology.
Selected Recent PublicationsYamano Y, Takenouchi N, Chris Grant, Li H-C, Tomaru U, Yao K, Maric D, and Jacobson SHuman T-cell lymphotropic virus type I (HTLV-I) induced dysfunction of CD4+CD25+ T cells breaks immunological self-tolerance
in patients with HTLV-I associated neurological disease - J Clin Invest
115 1361-1368 2005
Oh U, Yamano Y, Mora CA, Ohayon J, Bagnato F, Buttman J, Dambrosia J, Leist T, McFarland HF and Jacobson SInterferon-ƒÒ1a therapy for HTLV-I-associated Myelopathy / Tropical Spastic Paraparesis (HAM/TSP) Reduces HTLV-I-specific
CD8+ T cells: Analysis of HAM/TSP biomarkers - Annals of Neurology
57 526-534 2005
R Cassiani-Ingoni, H Greenstone, D Donati, A Fogdell-Hahn, E Martinelli, D Refai, R Martin, EA Berger and S JacobsonViral infection induces cell-cell fusion of human lymphocytes with oligodendrocytes through CD46 - Glia
2005
Semmes OJ, Cazares L, Ward M, Moody M, Bray S, Maloney E, Kisada M, Wright GL, Gygi S and Jacobson SDiscrete Protein Signatures Discriminate between Adult T-cell Leukemia and HTLV-1-Associated Myelopathy - Leukemia
19 (7) 1229-1238 2005
Yoshihisa Y, Cohen CJ, Tomaru U, Li HC, Takenouchi N, Biddison WE, Reiter Y, and Jacobson SIncreased expression of HTLV-I Tax11-19 peptide/HLA-A*201 complexes on CD4+CD25+ T cells detected by TCR-like antibody in
HAM/TSP patients - J. Exp.
199 1367-1377 2004
Donati D, Ahkyani N, Fogdell-Hahn A, Cermelli C, Vortmeyer A, Heiss JD, P. Cogen P, Gaillard WD, Sato S, Theodore WH, and
Jacobson SDetection of Human Herpesvirus 6 (HHV-6) in Mesial Temporal Lobe Epilepsy Surgical Brain Resections - Neurology
61 1405-1411 2003
Selected Earlier Publications
Contact InformationViral Immunology Section Neuroimmunology Branch, NINDS
Building 10, Room 5N-214
10 Center Drive, MSC 1400 Bethesda MD
20892-1400
Telephone:
301-496-
0519 (office), 301-
496-0519 (laboratory),
301-402-
0373 (fax), Email:
jacobsons@ninds.nih.gov